2014
DOI: 10.1016/j.jbi.2013.11.004
|View full text |Cite
|
Sign up to set email alerts
|

The National Institutes of Health’s Biomedical Translational Research Information System (BTRIS): Design, contents, functionality and experience to date

Abstract: The US National Institutes of Health (NIH) has developed the Biomedical Translational Research Information System (BTRIS) to support researchers’ access to translational and clinical data. BTRIS includes a data repository, a set of programs for loading data from NIH electronic health records and research data management systems, an ontology for coding the disparate data with a single terminology, and a set of user interface tools that provide access to identified data from individual research studies and data … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
26
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 32 publications
(26 citation statements)
references
References 27 publications
0
26
0
Order By: Relevance
“…The US National Institutes of Health established the Biomedical Translational Research Information System (BTRIS). It contains the information obtained not only through clinical practice, but also by means of experiments and clinical studies, and allows planning and performing translational, prospective and retrospective studies on the basis of the available data [26]. The establishments that are focused primarily on stage T2 ought to analyze and demonstrate effectiveness of the developed treatment strategies, which appeared efficient at T1 on the population level [27].…”
Section: Resultsmentioning
confidence: 99%
“…The US National Institutes of Health established the Biomedical Translational Research Information System (BTRIS). It contains the information obtained not only through clinical practice, but also by means of experiments and clinical studies, and allows planning and performing translational, prospective and retrospective studies on the basis of the available data [26]. The establishments that are focused primarily on stage T2 ought to analyze and demonstrate effectiveness of the developed treatment strategies, which appeared efficient at T1 on the population level [27].…”
Section: Resultsmentioning
confidence: 99%
“…CBC-D data was compiled and curated from the NIH CRC Biomedical Translational Research Information System (BTRIS) [30] and Clinical Research Information System (CRIS) databases (https://cris.cc.nih.gov/index.html). CBC data provides absolute counts by volume for overall WBCs, and absolute and relative counts for monocytes, lymphocytes, neutrophils, and eosinophils.…”
Section: Complete Blood Count With Differential (Cbc-d)mentioning
confidence: 99%
“…Ordering The NIH CC uses Allscripts Sunrise Clinical Manager 15.3 as the central component of the electronic health record, referred to as the Clinical Research Information System (CRIS). 5,6 With guidance from the PG Subcommittee, a pharmacogenomics CDS program that is completely integrated into the natural medication order pathway was implemented within the electronic health record. 7 The current program is based on our previous experience with iADRs corresponding to abacavir, allopurinol, and carbamazepine therapies, as discussed in Goldspiel et al 8 We have recently expanded this program to include genotyping drug-metabolizing and -transporting (DMET) genes, using the Affymetrix DMET Plus array that tests 1936 genetic variants in 235 pharmacogenes.…”
Section: Technical Implementationmentioning
confidence: 99%